Inscrição YC de zPREDICTA
zPREDICTA passou pela Y Combinator no batch Summer 2015 como uma empresa Healthcare. Abaixo: o que a empresa faz, quem a fundou e sua inscrição para a YC, reconstruída pergunta por pergunta no formulário real da YC.
- Batch YC
- Summer 2015
- Indústria
- HealthcareDrug Discovery and Delivery
- Tamanho da equipe
- 2
- Status
- Acquired
- Lançada
- 2015
Fundadores
Mukti ParikhFounder/CTO
O que zPREDICTA faz
zPREDICTA is developing organ-specific, physiologically-relevant 3D cell culture models providing a 1-to-1 reconstruction of human tissues. This is the only available 3D culture approach that comprehensively accounts for the major components of the cellular and extracellular tissue microenvironment preserving the critical interactions between a tumor and its surroundings. Clinical study data demonstrate the high correlation between drug efficacy measured in our platform and the clinical response. The ability of the zPREDICTA platform to reliably predict clinical outcomes offers superior compound attrition management, empowering researchers to exclude ineffective compounds while selecting agents with a high probability of success in the clinic. Our approach is compatible with any drug class, multiple tissue/cell types and a wide variety of readouts. Our customers are using these models for efficacy screening of anticancer compounds, including immuno-oncology agents, evaluation of mechanisms of drug resistance, the rescue of failed drug candidates, assessment of off-target toxicity, and a multitude other applications.
Inscrição YC de zPREDICTA, reconstruída
Inscrição Y Combinator
zPREDICTA, lote Summer 2015. As verdadeiras perguntas do formulário, respondidas com dados públicos.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
zPREDICTA
Patient-derived 3D tissue models for drug testing
We build organ-specific, physiologically relevant 3D cell culture models that reconstruct human tissues on a 1-to-1 scale. Our platform preserves interactions between tumors and their microenvironment, offering a better way to predict drug responses before clinical trials. Researchers use our models to screen anticancer compounds, study drug resistance, and evaluate toxicity.
We live in San Jose, CA, and plan to keep the company based here after YC.
San Jose is where our labs and early operations are set up, and it's close to the biomedical ecosystem we rely on. Staying here means maintaining easy access to patient samples and collaborators.
21 respostas a mais na inscrição completa
Founders, Progress, Idea, Equity, Curious, Batch Preference estão na versão completa. Crie uma conta gratuita para abri-la no YC Insights, ao lado de todos os outros batches da YC.
Perguntas Frequentes
Esta é a inscrição real da YC de zPREDICTA?
Não. A Y Combinator mantém as inscrições submetidas em privado. Esta é uma reconstrução: as perguntas reais do formulário da YC, respondidas a partir dos dados públicos de zPREDICTA (notas de lançamento, históricos de fundadores, descrição do produto). Mostra como uma empresa como zPREDICTA se apresentaria à YC, não o texto que eles submeteram.
Em qual batch da YC zPREDICTA esteve?
zPREDICTA fez parte do batch Summer 2015 da Y Combinator.
Quem fundou o zPREDICTA?
O zPREDICTA foi fundado por Mukti Parikh.
O que o zPREDICTA faz?
Patient-derived 3D tissue reconstruction models for preclinical…
Como eu leio o application completo reconstruído?
Crie uma conta gratuita no Round Funded. A versão completa de 26 respostas do application do zPREDICTA, e de todos os outros lotes do YC, está no YC Insights.
Mais startups YC como zPREDICTA
